Updated on 1 September 2026
Drug delivery system
CEO Office Director at CF PharmTech, Inc. 长风药业股份有限公司
China (Hong Kong)
About
RNA Delivery Technologies
We are seeking partners and technology providers advancing next-generation delivery platforms for RNA therapeutics — including alternatives and improvements to conventional lipid nanoparticles (LNPs), such as polymer-based carriers, extracellular vesicles, ligand-conjugate systems, and next-generation ionizable lipids targeting extra-hepatic tissues. We are particularly interested in platforms that improve payload capacity, tissue selectivity, manufacturability, and repeat-dose tolerability relative to first-generation systems. We welcome conversations with delivery-technology developers, platform companies, and academic or industry researchers holding validated or emerging IP relevant to mRNA, siRNA, ASO, or circular RNA delivery, with a view toward licensing, co-development, or sponsored research collaboration. Deal structures are open to negotiation depending on stage of development and IP position.
Looking for
- Public–private partnership / Concession
- Requisition of Service
Organisation
Similar opportunities
Project
Focusing on microRNA drug development and PDEV delivery system
- No
- Yes
- Technology
- Operations
- Private Project
- Equity (private)
- Transportation Services
- Information Technology Services
Yang Chao Chen
Director at Golden Biotech Limited
China (Hong Kong)
Project
Integrated platform-based innovative biopharma for inhalation formulations
- Yes
- Yes
- Bio-Tech
- Manufacturing
- Private Project
- Health Technology
- Medical Technology
- Financial Services
- Institutional Investment
- Secondary Market Financing
- Investment / Financing Discussion
Ting Su
IR at CF PharmTech, Inc. 长风药业股份有限公司
China
Project
Integrated platform-based innovative biopharma for inhalation formulations
- Yes
- Yes
- Bio-Tech
- Manufacturing
- Private Project
- Health Technology
- Medical Technology
- Financial Services
- Institutional Investment
- Secondary Market Financing
- Investment / Financing Discussion
Bill Liang
Chairperson & CEO at CF PharmTech, Inc. 长风药业股份有限公司
China